354 related articles for article (PubMed ID: 31818480)
21. Molecular docking studies and synthesis of novel bisbenzimidazole derivatives as inhibitors of α-glucosidase.
Özil M; Emirik M; Beldüz A; Ülker S
Bioorg Med Chem; 2016 Nov; 24(21):5103-5114. PubMed ID: 27576293
[TBL] [Abstract][Full Text] [Related]
22. Exploring efficacy of indole-based dual inhibitors for α-glucosidase and α-amylase enzymes: In silico, biochemical and kinetic studies.
Kawde AN; Taha M; Alansari RS; Almandil NB; Anouar EH; Uddin N; Rahim F; Chigurupati S; Nawaz M; Hayat S; Ibrahim M; Elakurthy PK; Vijayan V; Morsy M; Ibrahim H; Baig N; Khan KM
Int J Biol Macromol; 2020 Jul; 154():217-232. PubMed ID: 32173438
[TBL] [Abstract][Full Text] [Related]
23. In vitro and in silico inhibition properties of fucoidan against α-amylase and α-D-glucosidase with relevance to type 2 diabetes mellitus.
S LS; Raghu C; H A A; P A
Carbohydr Polym; 2019 Apr; 209():350-355. PubMed ID: 30732817
[TBL] [Abstract][Full Text] [Related]
24. Synthesis of Novel Benzimidazole-Based Thiazole Derivatives as Multipotent Inhibitors of α-Amylase and α-Glucosidase: In Vitro Evaluation along with Molecular Docking Study.
Hussain R; Iqbal S; Shah M; Rehman W; Khan S; Rasheed L; Rahim F; Dera AA; Kehili S; Elkaeed EB; Awwad NS; Bajaber MA; Alahmdi MI; Alrbyawi H; Alsaab HO
Molecules; 2022 Sep; 27(19):. PubMed ID: 36234994
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, biological evaluation and molecular docking study of N-arylbenzo[d]oxazol-2-amines as potential α-glucosidase inhibitors.
Wang G; Peng Z; Wang J; Li J; Li X
Bioorg Med Chem; 2016 Nov; 24(21):5374-5379. PubMed ID: 27614916
[TBL] [Abstract][Full Text] [Related]
26. Fluorinated indeno-quinoxaline bearing thiazole moieties as hypoglycaemic agents targeting
Gohar NA; Fayed EA; A Ammar Y; A Abu Ali O; Ragab A; Mahfoz AM; Abusaif MS
J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2367128. PubMed ID: 38913598
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and molecular docking studies of potent α-glucosidase inhibitors based on biscoumarin skeleton.
Khan KM; Rahim F; Wadood A; Kosar N; Taha M; Lalani S; Khan A; Fakhri MI; Junaid M; Rehman W; Khan M; Perveen S; Sajid M; Choudhary MI
Eur J Med Chem; 2014 Jun; 81():245-52. PubMed ID: 24844449
[TBL] [Abstract][Full Text] [Related]
28. Pyrano[2,3-b]chromone derivatives as novel dual inhibitors of α-glucosidase and α-amylase: Design, synthesis, biological evaluation, and in silico studies.
Farzaneh E; Mohammadi M; Raymand P; Noori M; Golestani S; Ranjbar S; Ghasemi Y; Mohammadi-Khanaposhtani M; Asadi M; Nasli Esfahani E; Rastegar H; Larijani B; Mahdavi M; Taslimi P
Bioorg Chem; 2024 Apr; 145():107207. PubMed ID: 38402795
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, α-glucosidase inhibition and molecular docking study of coumarin based derivatives.
Taha M; Shah SAA; Afifi M; Imran S; Sultan S; Rahim F; Khan KM
Bioorg Chem; 2018 Apr; 77():586-592. PubMed ID: 29477126
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, in vitro α-glucosidase inhibitory potential and molecular docking study of thiadiazole analogs.
Javid MT; Rahim F; Taha M; Rehman HU; Nawaz M; Wadood A; Imran S; Uddin I; Mosaddik A; Khan KM
Bioorg Chem; 2018 Aug; 78():201-209. PubMed ID: 29597114
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, α-amylase and α-glucosidase inhibition and molecular docking studies of indazole derivatives.
Nawaz M; Taha M; Qureshi F; Ullah N; Selvaraj M; Shahzad S; Chigurupati S; Abubshait SA; Ahmad T; Chinnam S; Hisaindee S
J Biomol Struct Dyn; 2022; 40(21):10730-10740. PubMed ID: 34463216
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, α-glucosidase inhibitory, cytotoxicity and docking studies of 2-aryl-7-methylbenzimidazoles.
Taha M; Ismail NH; Imran S; Mohamad MH; Wadood A; Rahim F; Saad SM; Rehman AU; Khan KM
Bioorg Chem; 2016 Apr; 65():100-9. PubMed ID: 26894559
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, α-glucosidase and α-amylase inhibitory activities, acute toxicity and molecular docking studies of thiazolidine-2,4-diones derivatives.
Fettach S; Thari FZ; Hafidi Z; Tachallait H; Karrouchi K; El Achouri M; Cherrah Y; Sefrioui H; Bougrin K; Faouzi MEA
J Biomol Struct Dyn; 2022 Nov; 40(18):8340-8351. PubMed ID: 33847536
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, α-glucosidase inhibitory and molecular docking studies of prenylated and geranylated flavones, isoflavones and chalcones.
Sun H; Li Y; Zhang X; Lei Y; Ding W; Zhao X; Wang H; Song X; Yao Q; Zhang Y; Ma Y; Wang R; Zhu T; Yu P
Bioorg Med Chem Lett; 2015 Oct; 25(20):4567-71. PubMed ID: 26351039
[TBL] [Abstract][Full Text] [Related]
35. A new series of Schiff base derivatives bearing 1,2,3-triazole: Design, synthesis, molecular docking, and α-glucosidase inhibition.
Nasli-Esfahani E; Mohammadi-Khanaposhtani M; Rezaei S; Sarrafi Y; Sharafi Z; Samadi N; Faramarzi MA; Bandarian F; Hamedifar H; Larijani B; Hajimiri M; Mahdavi M
Arch Pharm (Weinheim); 2019 Aug; 352(8):e1900034. PubMed ID: 31330079
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, in vitro evaluation and molecular docking studies of biscoumarin thiourea as a new inhibitor of α-glucosidases.
Zawawi NK; Taha M; Ahmat N; Ismail NH; Wadood A; Rahim F; Rehman AU
Bioorg Chem; 2015 Dec; 63():36-44. PubMed ID: 26432614
[TBL] [Abstract][Full Text] [Related]
37. Discovery of novel 6-(piperidin-1-ylsulfonyl)-2H-chromenes targeting α-glucosidase, α-amylase, and PPAR-γ: Design, synthesis, virtual screening, and anti-diabetic activity for type 2 diabetes mellitus.
Thabet HK; Abusaif MS; Imran M; Helal MH; Alaqel SI; Alshehri A; Mohd AA; Ammar YA; Ragab A
Comput Biol Chem; 2024 Aug; 111():108097. PubMed ID: 38772048
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis and docking study of novel tetracyclic oxindole derivatives as α-glucosidase inhibitors.
Han K; Li Y; Zhang Y; Teng Y; Ma Y; Wang M; Wang R; Xu W; Yao Q; Zhang Y; Qin H; Sun H; Yu P
Bioorg Med Chem Lett; 2015 Apr; 25(7):1471-5. PubMed ID: 25759031
[TBL] [Abstract][Full Text] [Related]
39. Rational in silico design of novel α-glucosidase inhibitory peptides and in vitro evaluation of promising candidates.
Ibrahim MA; Bester MJ; Neitz AW; Gaspar ARM
Biomed Pharmacother; 2018 Nov; 107():234-242. PubMed ID: 30096627
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, biological evaluation, and docking studies of novel 5,6-diaryl-1,2,4-triazine thiazole derivatives as a new class of α-glucosidase inhibitors.
Wang G; Peng Z; Gong Z; Li Y
Bioorg Chem; 2018 Aug; 78():195-200. PubMed ID: 29587132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]